These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11581236)

  • 1. Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia.
    Zhang L; Li XZ; Poole K
    J Antimicrob Chemother; 2001 Oct; 48(4):549-52. PubMed ID: 11581236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia.
    Isenberg HD; Alperstein P; France K
    Diagn Microbiol Infect Dis; 1999 Feb; 33(2):81-6. PubMed ID: 10091030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.
    Saiman L; Chen Y; Gabriel PS; Knirsch C
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1105-7. PubMed ID: 11897598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine.
    Ribera A; Jurado A; Ruiz J; Marco F; Del Valle O; Mensa J; Chaves J; Hernández G; Jiménez de Anta MT; Vila J
    Diagn Microbiol Infect Dis; 2002 Feb; 42(2):123-8. PubMed ID: 11858908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interpretative reading of the non-fermenting gram-negative bacilli antibiogram].
    Vila J; Marco F
    Enferm Infecc Microbiol Clin; 2002; 20(6):304-10; quiz 311-2. PubMed ID: 12084355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological and biological relationship among flagellin of Pseudomonas aeruginosa, Burkholderia cepacia and Stenotrophomonas maltophilia.
    Zgair AK; Chhibber S
    Mikrobiologiia; 2012; 81(3):371-6. PubMed ID: 22880399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of eight fluoroquinolones against multiresistant Stenotrophomonas maltophilia.
    Sánchez-Hernández J; Manzanares MA; Gutiérrez Zufiaurre MN; Muñoz Criado S; Muñoz Bellido JL; García-Rodríguez JA
    Rev Esp Quimioter; 1999 Sep; 12(3):234-6. PubMed ID: 10878514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model.
    Ba BB; Feghali H; Arpin C; Saux MC; Quentin C
    Antimicrob Agents Chemother; 2004 Mar; 48(3):946-53. PubMed ID: 14982788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.
    Zhang L; Li XZ; Poole K
    Antimicrob Agents Chemother; 2000 Feb; 44(2):287-93. PubMed ID: 10639352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro killing effect of moxifloxacin on clinical isolates of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole.
    Giamarellos-Bourboulis EJ; Karnesis L; Galani I; Giamarellou H
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3997-9. PubMed ID: 12435710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of β-lactams in combination with avibactam against multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Achromobacter xylosoxidans isolates from patients with cystic fibrosis.
    Mathy V; Grohs P; Compain F
    J Med Microbiol; 2018 Sep; 67(9):1217-1220. PubMed ID: 30016231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Accumulation and efflux of quinolones by clinical isolates of Stenotrophomonas maltophilia].
    Sánchez P; Alonso A; Campanario E; Alós I; Martíinez JL
    Rev Esp Quimioter; 2000 Jun; 13(2):176-81. PubMed ID: 10918091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies.
    Grillon A; Schramm F; Kleinberg M; Jehl F
    PLoS One; 2016; 11(6):e0156690. PubMed ID: 27257956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Pseudomonas aeruginosa, Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR.
    da Silva Filho LV; Tateno AF; Velloso Lde F; Levi JE; Fernandes S; Bento CN; Rodrigues JC; Ramos SR
    Pediatr Pulmonol; 2004 Jun; 37(6):537-47. PubMed ID: 15114555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.
    Jia W; Wang J; Xu H; Li G
    Int J Environ Res Public Health; 2015 May; 12(5):5177-95. PubMed ID: 25985315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surveillance on antibiotic resistance of Stenotrophomonas maltophilia in Chengdu and Chongqing area].
    Tao CM; Li XC; Lü XJ; Li P; Yu RJ; Gao YY; Chen HL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):91-3. PubMed ID: 14981826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro susceptibilities of Pseudomonas aeruginosa and Pseudomonas spp. to the new fluoroquinolones clinafloxacin and PD 131628 and nine other antimicrobial agents.
    Ford AS; Baltch AL; Smith RP; Ritz W
    J Antimicrob Chemother; 1993 Apr; 31(4):523-32. PubMed ID: 8390434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in-vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sparfloxacin (CI-978, AT-4140, PD131501) and reference antimicrobial agents.
    Louie A; Baltch AL; Ritz WJ; Smith RP
    J Antimicrob Chemother; 1991 Jun; 27(6):793-9. PubMed ID: 1657857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone-resistant mutants of Burkholderia cepacia.
    Pope CF; Gillespie SH; Pratten JR; McHugh TD
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1201-3. PubMed ID: 18160522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interpretive reading of the non-fermenting gram-negative bacilli antibiogram].
    Vila J; Marco F
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):726-36. PubMed ID: 20579775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.